No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs147459863 |
chr3:89482935-89482936 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs530667705 |
chr3:89483067-89483068 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs112095078 |
chr3:89483090-89483091 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs567276560 |
chr3:89483148-89483149 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs191202173 |
chr3:89483198-89483199 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs540257169 |
chr3:89483286-89483287 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs544888667 |
chr3:89483351-89483352 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs550736069 |
chr3:89483353-89483354 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs184786970 |
chr3:89483370-89483371 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs189204557 |
chr3:89483379-89483380 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs35071595 |
chr3:89483385-89483386 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs139927302 |
chr3:89483409-89483410 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs376764249 |
chr3:89483417-89483418 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs369803165 |
chr3:89483421-89483422 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs557958272 |
chr3:89483436-89483437 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs576443601 |
chr3:89483486-89483487 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs543912127 |
chr3:89483488-89483489 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs192093782 |
chr3:89483524-89483525 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs573980306 |
chr3:89483541-89483542 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs575157084 |
chr3:89483604-89483605 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs184490270 |
chr3:89483666-89483667 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs564197195 |
chr3:89483681-89483682 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs559674382 |
chr3:89483695-89483696 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs564435235 |
chr3:89483705-89483706 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs190195708 |
chr3:89483746-89483747 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs533221979 |
chr3:89483766-89483767 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs545200095 |
chr3:89483790-89483791 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs114974989 |
chr3:89483879-89483880 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs531658096 |
chr3:89483880-89483881 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs546812803 |
chr3:89483904-89483905 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs530496172 |
chr3:89483971-89483972 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs549068036 |
chr3:89484002-89484003 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs181408483 |
chr3:89484029-89484030 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs186421130 |
chr3:89484034-89484035 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs546236810 |
chr3:89484062-89484063 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs566012688 |
chr3:89484090-89484091 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs572560178 |
chr3:89484109-89484110 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs189255347 |
chr3:89484111-89484112 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs180734003 |
chr3:89484113-89484114 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs186465603 |
chr3:89484123-89484124 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs539940493 |
chr3:89484152-89484153 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs111695037 |
chr3:89484165-89484166 |
Enhancers Flanking Active TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs570250606 |
chr3:89484205-89484206 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs373638614 |
chr3:89484228-89484229 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs190847587 |
chr3:89484239-89484240 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs1028013 |
chr3:89484268-89484269 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
47 |
rs574088460 |
chr3:89484333-89484334 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs112355332 |
chr3:89484369-89484370 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs535012681 |
chr3:89484377-89484378 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs369351475 |
chr3:89484464-89484465 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|